Retrospective analysis of cisapride-induced QT changes in end-stage renal disease patients

Nephrology Dialysis Transplantation

Volumn 15, Issue 11, 2000, Pages 1814-1818

  Hentges, Melissa J ^a   Gunderson, Brent W ^b   Lewis, Matthew J ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cisapride; End stage renal disease; Haemodialysis; QT interval; Qtc interval

Indexed keywords

AMIODARONE; CISAPRIDE; SEROTONIN AGONIST;

ADULT; ANAMNESIS; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DATA ANALYSIS; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STOMACH PARESIS; SYMPTOM; SYNCOPE; TORSADE DES POINTES;

EID: 0033761578     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.11.1814     Document Type: Article

References (20)

1. Cisapride: An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders
2. Cisapride and fatal arrhythmias
3. Tachycardia during cisapride treatment
4. Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin
5. Syncopal episodes associated with cisapride and concurrent drugs
6. Cisapride-induced torsades de pointes
7. Cisapride-induced long QT interval
8. Torsades de pointes induced by cisapride/clarithromycin interaction
9. Prolongation of the QT interval related to cisapride-diltiazem interaction
10. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients
11. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate between variables
12. Malnutrition as the main factor in morbidity and mortality of hemodialysis patients
13. Canadian hemodialysis morbidity study
14. Cisapride: A gastrointestinal prokinetic drug
15. Pharmacokinetics and pharmacodynamics of cisapride in patients undergoing hemodialysis
16. How to measure the QT interval-what is normal?
17. Variability of the QTc interval: Impact on defining drug effect and low-frequency cardiac event
18. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: Definitions and mechanisms
19. QT interval: A measure of drug action
20. Rate-corrected QT interval: Techniques and limitations